Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma.
Abstract
PURPOSE AND METHODS: To assess patients with high-grade osteosarcoma treated at our institution for various prognostic factors for the development of local recurrence of disease. Follow-up data were available for all patients and the mean follow-up duration was 65 months in surviving patients. RESULTS: There were 28 local recurrences in this study (7%). Of these, only three patients (11%) were alive at the most recent follow-up point, 28, 53, and 54 months after local recurrence. None of 59 patients who were treated primarily with a radical amputation and none of 10 who underwent a rotationplasty developed local recurrence. Four of 48 patients (8%) who had wide amputations, one of whom had an intralesional amputation, and 23 of 237 (10%) who had limb-salvage surgery developed locally recurrent disease. Of 237 patients who underwent limb-sparing resection, three prognostic factors for local control were identified. The strongest association with local recurrence was chemotherapy response (P < .0001), followed closely by surgical margins (P = .0001). Older patients were more likely to have locally recurrent disease (P = .033), with each decade of life older than the first decade having a relative risk of 1.5 times greater per decade (SE = 0.16; 95% confidence interval, 0.034 to .0650). Factors that were not associated with local recurrence included sex, date of diagnosis, and anatomic site of disease. CONCLUSION: Chemotherapy-induced tumor necrosis and surgical margins are important prognostic factors for local control of patients with osteosarcoma.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Osteosarcoma cells express high levels of GD2 antigen.
“Osteosarcoma cells express high level GD2 antigen that can be a potential target [108].”
From Advances on immunotherapy for osteosarcoma (2024) · cites this paper as [108]
Intralesional or marginal resections increase local recurrence rate, which is associated with reduced overall survival.
“Otherwise, intralesional or marginal resections increase local recurrence rate, which is associated with reduced overall survival 2,134 .”
From Osteosarcoma (2022) · cites this paper as [134]
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,232 · see citing works
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297 · see citing works
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,516 · see citing works
Link, M. P., Goorin, A. M., Miser, A. W., Green, A. A., Pratt, C. B., Belasco, J. B., Pritchard, J., Malpas, J. S., Baker, A. R., Kirkpatrick, J. A., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142502 · Cited by 1,203 · see citing works
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Meyers, P. A., Heller, G., Healey, J. H., Huvos, A. G., Lane, J. M., Marcove, R. C., Applewhite, A., Vlamis, V., & Rosen, G. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.5 · Cited by 675 · see citing works
Rougraff, B. T., Simon, M. A., Kneisl, J. S., Greenberg, D. B., & Mankin, H. J. (1994) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199405000-00004 · Cited by 534 · see citing works
Self-citationLimb-Salvage Treatment Versus Amputation for Osteosarcoma of the Distal End of the Femur
Simon, M. A., Aschliman, M. A., Thomas, N. J., & Mankin, H. J. (2005) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.8712.cl · Cited by 452 · see citing works
Current concepts review. The surgical staging of musculoskeletal sarcoma.
Enneking, W. F., Spanier, S. S., & Goodman, M. A. (1980) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-198062060-00028 · Cited by 335 · see citing works
Link, M., Goorin, A. M., Horowitz, M. M., et al. (1991) · PubMed · Cited by 259 · see citing works
Salvage of the limb in the treatment of malignant pelvic tumors.
O’Connor, M., & Sim, F. H. (1989) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-198971040-00002 · Cited by 244 · see citing works
Bacci, G., Picci, P., Ruggieri, P., Mercuri, M., Avella, M., Capanna, R., del Prever, A. B., Mancini, A., Gherlinzoni, F., Padovani, G., et al. (1990) · Cancer · doi:10.1002/1097-0142(19900601)65:11 · Cited by 233 · see citing works
Self-citationDavis, S., Wright, P. W., Schulman, S. F., Hill, L. D., Pinkham, R. D., Johnson, L. P., Jones, T. W., Kellogg, H. B., Radke, H., Sikkema, W. W., et al. (1985) · Cancer · doi:10.1002/1097-0142(19851001)56:7 · Cited by 154 · see citing works
Surgical treatment for osteosarcoma.
Springfield, D. S., Schmidt, R., Graham‐Pole, J., et al. (1988) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-198870080-00002 · Cited by 111 · see citing works
Endoprosthetic Replacement for Stage IIB Osteosarcoma
Eċkardt, J. J., Eilber, F. R., Rosen, G., et al. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199109000-00027 · Cited by 110 · see citing works
Oncologic Outcomes of Primary Bone Sarcomas of the Pelvis
Shin, K. H., Rougraff, B. T., & Simon, M. A. (1994) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199407000-00033 · Cited by 108 · see citing works
Self-citationOsteosarcoma of the pelvis. A clinical and histopathological study of twenty-five patients.
Fahey, M., Spanier, S. S., & Griend, R. A. V. (1992) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199274030-00002 · Cited by 92 · see citing works
Clear cell carcinoma of the inguinal region arising from endometriosis
Ahn, G., & Scully, R. E. (1991) · Cancer · doi:10.1002/1097-0142(19910101)67:1 · Cited by 47 · see citing works
Bezwoda, W. R., Derman, D. P., Bothwell, T. H., Bsc, P. M., Levin, J., Rad, D., & de Moor, N. G. (1981) · Cancer · doi:10.1002/1097-0142(19811001)48:7 · Cited by 46 · see citing works
Unusual presentation of extranodal peripheral T-cell lymphomas with multiple paraneoplastic features
Díez-Martín, J. L., Lust, J. A., Witzig, T. E., Banks, P. M., & Li, C.-Y. (1991) · Cancer · doi:10.1002/1097-0142(19910815)68:4 · Cited by 29 · see citing works
Jaffe, N., SMITH, D., JAFFE, M. R., et al. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199109000-00004 · Cited by 20 · see citing works
Marsden, F. W., Stephens, F. O., McCarthy, S., et al. (1991) · PubMed · Cited by 20 · see citing works
Spontaneous Necrosis in Osteosarcoma
Springfield, D. S., Schakel, M., & Spanier, S. S. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199102000-00029 · Cited by 15 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393 · see citing works
Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660 · see citing works
Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy310 · Cited by 617 · see citing works
Self-citationAdvances on immunotherapy for osteosarcoma
Yu, S., & Yao, X. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02105-9 · Cited by 270 · see citing works
“Osteosarcoma cells express high level GD2 antigen that can be a potential target [108].”
BackgroundBielack, S. S., Kempf-Bielack, B., Branscheid, D., Carrle, D., Friedel, G., Helmke, K., Kevric, M., Jundt, G., Kühne, T., Maas, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.2305 · Cited by 238 · see citing works
Current Concepts in the Evaluation and Treatment of Osteosarcoma
Papagelopoulos, P. J., Galanis, E. C., Vlastou, C., Nikiforidis, P. A., Vlamis, J. A., Boscainos, P. J., Fragiadakis, E. G., Stamos, K. G., Pantazopoulos, T., & Sim, F. H. (2000) · Orthopedics · doi:10.3928/0147-7447-20000801-11 · Cited by 42 · see citing works
- Authors
- Picci, P., Sangiorgi, L., Rougraff, B. T., Neff, J. R., Casadei, R., & Campanacci, M.
- Affiliations
- Istituto Ortopedico Rizzoli (IT)
- Venue
- Journal of Clinical Oncology
- Published
- 1994-12
- Volume
- 12
- Issue
- 12
- Pages
- 2699-2705
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1911184691
- Cited by
- 300
- References
- 22
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 13 · 2019: 7 · 2018: 4 · 2017: 7 · 2016: 9 · 2015: 8 · 2014: 26 · 2013: 10 · 2012: 11
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoma Diagnosis and Treatment
- Health Sciences › Medicine › Rheumatology › Bone Tumor Diagnosis and Treatments
- Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
- Keywords
- osteosarcoma, local recurrence, surgical margins, limb-sparing surgery, amputation, rotationplasty, prognostic factors, chemotherapy response, age as risk factor, local control
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Amputation, Surgical, Antineoplastic Combined Chemotherapy Protocols, Bone Neoplasms, Child, Child, Preschool, Combined Modality Therapy, Follow-Up Studies, Humans, Middle Aged, Necrosis, Neoplasm Recurrence, Local, Prognosis, Retrospective Studies, Risk Factors, Osteosarcoma, Incidence, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review